<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">The genome of SARS-CoV continues to mutate during replication, and many virus subtypes already exist. Therefore, the targets of antibodies need to extensively cover different SARS-CoV isolates and control potential neutralization escape mutations for effective human immune prophylaxis. Combinations of neutralizing and noncompetitive mAbs may have these properties.
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup>
</p>
